STOCK TITAN

[8-K] DATA I/O CORP Reports Material Event

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Data I/O Corporation entered into a private financing agreement with the Lytton-Kambara Foundation and the Alice W. Lytton Family LLC for an aggregate purchase price of $9 million. The deal includes 869,840 shares of common stock, a five-year convertible note with a principal amount of $6,825,400 bearing 4% annual interest, and warrants for 1,080,000 common shares at $3.00 per share.

The note is convertible into Series B Convertible Preferred Stock at $1,000 per preferred share and may automatically convert if shareholders approve a proposal at the 2026 annual meeting. Each preferred share carries a 4% cumulative dividend on its $1,000 stated value and is initially convertible into common stock at $2.50 per share, subject to adjustment. Warrants are exercisable for five years, and conversions or exercises are limited by a 9.99% beneficial ownership cap and an aggregate Investor Issuance Cap of 1,869,470 common shares. The securities are being issued in a private placement under Regulation D exemptions, with the company agreeing to register the resale of the underlying common shares.

Positive

  • None.

Negative

  • None.

Insights

Data I/O secures $9M in structured, equity-linked private financing.

The transaction provides Data I/O with $9 million of capital through a mix of common stock, a $6,825,400 convertible note, and 1,080,000 warrants. The note carries 4% interest over five years and can convert into Series B Convertible Preferred Stock at $1,000 per share.

The preferred stock offers a 4% cumulative dividend on its $1,000 stated value and is initially convertible into common shares at $2.50, with standard anti-dilution adjustments. A 9.99% beneficial ownership cap and a 1,869,470-share Investor Issuance Cap limit common stock issuance absent shareholder approval.

The financing is exempt from registration under Section 4(a)(2) and Regulation D, with investors represented as accredited or qualified institutional buyers. Future registration of resale shares and the outcome of the 2026 shareholder proposal on automatic note conversion will further shape the company’s capital structure.

Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Aggregate purchase price $9,000,000 Total consideration for shares, note and warrants
Common shares issued 869,840 shares Shares of common stock sold in private placement
Convertible note principal $6,825,400 Five-year note principal amount
Note interest rate 4.0% per annum Payable semiannually and on conversion or maturity
Warrants issued 1,080,000 shares Common shares underlying warrants at $3.00 exercise price
Warrant exercise price $3.00 per share Exercise price for five-year warrants
Preferred conversion price $2.50 per share Initial common stock conversion price for preferred
Investor Issuance Cap 1,869,470 shares Maximum aggregate common shares issuable absent shareholder approval
Securities Purchase Agreement financial
"the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Lytton-Kambara Foundation"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
convertible debentures financial
"convertible debentures in the principal amount of $6,825,400.00 (the “Note”)"
Convertible debentures are loans a company issues that pay interest like a bond but can be swapped later for the company’s shares at a set price. For investors they act like a safety-net plus a shortcut: you get regular interest payments while retaining the option to join ownership if the share price rises, which offers upside potential but can dilute existing shareholders if conversion occurs.
Series B Convertible Preferred Stock financial
"Terms of the Series B Convertible Preferred Stock The Preferred Stock is non-voting, except as required by law."
Series B convertible preferred stock is a class of shares sold during a later-stage private financing that combines features of a loan and common stock: it usually pays priority dividends or has a priority claim if the company is sold, and it can be converted into common shares under predefined rules. Investors care because these shares affect ownership stakes and payout order—like having a reserved place in line and a ticket that can turn into regular ownership—so they influence potential returns and dilution for other shareholders.
Accruing Dividends financial
"shall accrue on each share then outstanding (the “Accruing Dividends”)."
Investor Issuance Cap financial
"the aggregate number of shares issued would exceed 1,869,470 shares of Common Stock (collectively, the “Investors Issuance Cap”)."
accredited investor financial
"Each of the Investors has represented that it is an accredited investor within the meaning of Rule 501(a) of Regulation D"
An accredited investor is an individual or entity that meets certain financial criteria, such as having a high income or significant net worth, allowing them to invest in private or less regulated investment opportunities. This status matters because it grants access to investments that are often riskier or less available to the general public, reflecting a higher level of financial knowledge or resources.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

FORM 8-K

 

CURRENT REPORT

 Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 14, 2026

 

Data I/O Corporation

(Exact name of registrant as specified in its charter)

 

Washington

 

0-10394

 

91-0864123

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

6645 185th Ave. N.E., Suite 100, Redmond, WA 98052

(Address of principal executive offices, including zip code)

 

 (425) 881-6444

(Registrant’s telephone number, including area code)

 

 Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐ 

 

 

 

  

Items reported in this filing:

Item 3.02 Unregistered Sales of Equity Securities.

Item 8.01 Other Events.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

As previously disclosed by Data I/O Corporation (the “Company”) on the press release attached as Exhibit 99.2 to Item 7.01 on the Current Report on Form 8-K filed on May 15, 2026, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Lytton-Kambara Foundation and Alice W. Lytton Family LLC (the “Investors”) for the sale and issuance to the Investors of securities consisting of the following: 869,840 shares of Common Stock (the “Shares”), convertible debentures in the principal amount of $6,825,400.00 (the “Note”) and warrants to purchase an aggregate of 1,080,000 shares of common stock (the “Warrant”) for an aggregate purchase price of $9 million.  The completion of the private placement is subject to customary closing conditions, including regulatory approval.

 

Terms of the Note

 

The five-year Note bears interest at a rate of 4.0% per annum, payable at semiannually on November 1 and May 1, beginning on the first such date after the original issue date of the note, on each conversion date (as to that principal amount then being converted), and on the maturity date. The interest is paid in cash, or at the Company’s option and under certain circumstances, in Preferred Stock.  The Investors may convert the Note into Shares of Preferred Stock at the conversion price.  The conversion price is $1,000 per share of Preferred Stock. Upon an event of default, the default interest rate increases to 18% per annum.  If shareholders approve a proposal that is to be proposed at the Company’s 2026 annual meeting of shareholders, the Note will automatically convert into Preferred Stock.

 

Terms of the Series B Convertible Preferred Stock

 

The Preferred Stock is non-voting, except as required by law.  The Preferred Stock accrues dividends at the rate per annum of 4% of the Stated Value of such share, plus the amount of previously accrued dividends, compounded annually, shall accrue on each share then outstanding (the “Accruing Dividends”). Accruing Dividends shall accrue from day to day, whether or not declared, and shall be cumulative.  The Stated Value is $1,000 per share.  Each share of Preferred Stock shall be convertible into that number of shares of Common Stock (subject to the limitations set forth in the Certificate of Designation relating to limitations on beneficial ownership and the Investor Issuance Cap) determined by dividing the Stated Value plus any Accruing Dividends of such share of Preferred Stock by the Conversion Price.  The initial conversion price is $2.50 per share of common stock and it subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock.  If the principal amount of the Note was converted into Preferred Stock, the Stated Value of the Preferred Stock, without regard to Accruing Dividends of, would be convertible into approximately 2.73 million shares of common stock (subject to the limitations set forth in the Certificate of Designation relating to limitations on beneficial ownership and the Investor Issuance Cap).

 

 
2

 

 

Terms of the Warrants

 

The Warrants are exercisable for an aggregate of 1,080,000 shares of common stock at $3.00 per share for a period of five years. The exercise price is subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock.

 

The Note, the Preferred Stock and the Warrants are referred to as the “Convertible Securities.” The Convertible Securities may not be converted or exercised into shares of Common Stock to the extent (i) such conversion or issuance would result in the investor having beneficial ownership of more than 9.99% of then outstanding shares of Common Stock or (ii) absent stockholder approval, the aggregate number of shares issued would exceed 1,869,470 shares of Common Stock (collectively, the “Investors Issuance Cap”).

 

The Shares and Convertible Securities to be issued and sold will be exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the Securities Act and/or Regulation D under the Securities Act (“Regulation D”), and in reliance on similar exemptions under applicable state laws. The Company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares of common stock to be issued in the transaction as well as the common stock issuable upon the exercise of the Warrants and upon conversion of the Preferred Stock.

 

Each of the Investors has represented that it is an accredited investor within the meaning of Rule 501(a) of Regulation D or a qualified institutional buyer as that term is defined in Rule 144A(a) under the Securities Act, and will be acquiring the Shares and Convertible Securities for investment purposes only and not with a view to any future distribution or sale in violation of applicable securities laws. The Shares and Convertible Securities were offered without any general solicitation by the Company or its representatives.

 

Item 8.01 Other Events.

 

The information set forth in Item 3.02 above is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K. 

 

 
3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Data I/O Corporation

    
May 19, 2026By:/s/ Charles J. DiBona

 

 

Charles J. DiBona

 
  

Chief Financial Officer

 
    

 

 
4

 

Filing Exhibits & Attachments

5 documents